• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植脂肪变性的评估:我们目前的状况如何?

Assessment of Liver Graft Steatosis: Where Do We Stand?

作者信息

Cesaretti Manuela, Addeo Pietro, Schiavo Luigi, Anty Rodolphe, Iannelli Antonio

机构信息

Department of HPB Surgery and Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, France.

Department of Nanophysics, Italian Institute of Technology, Genova, Italy.

出版信息

Liver Transpl. 2019 Mar;25(3):500-509. doi: 10.1002/lt.25379.

DOI:10.1002/lt.25379
PMID:30380197
Abstract

The growing number of patients on waiting lists for liver transplantation and the shortage of organs have forced many centers to adopt extended criteria for graft selection, moving the limit of acceptance for marginal livers. Steatotic grafts that were, in the past, considered strictly unacceptable for transplantation because of the high risk of early nonfunction are now considered as a potential resource for organ implementation. Several methods to diagnose, measure, classify, and stage steatosis exist, but none can be considered qualitatively and quantitatively "the ideal method" to date. Clinical, biological, and imaging data can be very helpful to estimate graft steatosis, but histology still remains the gold standard. There is an increasing need for rapid and reliable tools to assess graft steatosis. Herein, we present a comprehensive review of the approaches that are currently used to quantify steatosis in liver grafts.

摘要

等待肝移植的患者数量不断增加以及器官短缺,迫使许多中心采用更宽泛的移植物选择标准,放宽了对边缘性肝脏的接受限度。过去因早期无功能风险高而被认为绝对不适合移植的脂肪变性移植物,如今被视为器官移植的潜在资源。目前存在多种诊断、测量、分类和分期脂肪变性的方法,但迄今为止,尚无一种方法能在定性和定量方面被视为“理想方法”。临床、生物学和影像学数据对评估移植物脂肪变性非常有帮助,但组织学仍是金标准。对快速且可靠的移植物脂肪变性评估工具的需求日益增加。在此,我们对目前用于量化肝移植物脂肪变性的方法进行全面综述。

相似文献

1
Assessment of Liver Graft Steatosis: Where Do We Stand?肝移植脂肪变性的评估:我们目前的状况如何?
Liver Transpl. 2019 Mar;25(3):500-509. doi: 10.1002/lt.25379.
2
The "Skinny" on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review.脂肪变性肝脏移植物评估与应用要点:一项系统综述
Liver Transpl. 2019 Mar;25(3):488-499. doi: 10.1002/lt.25408.
3
Steatotic donor livers: Where is the risk-benefit maximized?脂肪变性供肝:风险效益最大化体现在何处?
Liver Transpl. 2017 Oct;23(S1):S34-S39. doi: 10.1002/lt.24826.
4
Use of Steatotic Grafts in Liver Transplantation: Current Status.肝移植中使用脂肪肝移植物:现状。
Liver Transpl. 2019 May;25(5):771-786. doi: 10.1002/lt.25430. Epub 2019 Apr 5.
5
Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.通过优选受者匹配,降低脂肪变性供肝肝移植的风险。
Transplantation. 2020 Aug;104(8):1604-1611. doi: 10.1097/TP.0000000000003052.
6
Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region.优化老年肝脏在欧洲器官移植区域的使用。
Liver Transpl. 2019 Feb;25(2):260-274. doi: 10.1002/lt.25353.
7
Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.美国拒绝接受脂肪肝供肝的肝移植候选者的预后情况。
Transplantation. 2020 Aug;104(8):1612-1618. doi: 10.1097/TP.0000000000003062.
8
Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.大脂变同种异体移植物和肥胖受者对肝移植存活的负面影响几乎相等。
Transplantation. 2020 Jun;104(6):1193-1200. doi: 10.1097/TP.0000000000002990.
9
Use of severely steatotic grafts in liver transplantation: a matched case-control study.肝移植中严重脂肪变性移植物的应用:一项配对病例对照研究。
Ann Surg. 2007 Dec;246(6):940-6; discussion 946-8. doi: 10.1097/SLA.0b013e31815c2a3f.
10
Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?通过磁共振成像质子密度脂肪分数测定的可忽略不计的肝脂肪变性是否可以免除潜在肝供体的肝活检?
Liver Transpl. 2018 Apr;24(4):470-477. doi: 10.1002/lt.24965. Epub 2018 Mar 6.

引用本文的文献

1
Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion.供体肥胖对小儿肝移植的影响;当前证据及扩大供肝库的潜力
World J Transplant. 2025 Sep 18;15(3):103015. doi: 10.5500/wjt.v15.i3.103015.
2
Soluble CD46 improves detection of hepatic steatosis by contrast-enhanced computed tomography before liver surgery.可溶性CD46可改善肝脏手术前通过对比增强计算机断层扫描对肝脂肪变性的检测。
Int J Surg. 2025 Jun 1;111(6):4086-4089. doi: 10.1097/JS9.0000000000002422. Epub 2025 Apr 25.
3
Quantitative contrast-enhanced ultrasonography in the diagnosis and grading of hepatic steatosis in brain-dead donors.
定量对比增强超声在脑死亡供体肝脂肪变性诊断及分级中的应用
Quant Imaging Med Surg. 2025 Jan 2;15(1):326-338. doi: 10.21037/qims-24-1004. Epub 2024 Dec 16.
4
Use of Ex Situ Machine Perfusion for Liver Transplantation: The National Experience.异位机器灌注在肝移植中的应用:国家经验
Transplantation. 2025 Jun 1;109(6):967-975. doi: 10.1097/TP.0000000000005290. Epub 2024 Dec 26.
5
TARGETING S100A9-TLR2 AXIS CONTROLS MACROPHAGE NLRP3 INFLAMMASOME ACTIVATION IN FATTY LIVER ISCHEMIA REPERFUSION INJURY.靶向S100A9-TLR2轴可控制脂肪肝缺血再灌注损伤中巨噬细胞NLRP3炎性小体的激活。
Shock. 2025 Feb 1;63(2):292-298. doi: 10.1097/SHK.0000000000002470. Epub 2024 Oct 21.
6
Evaluation of Minimum-to-Severe Global and Macrovesicular Steatosis in Human Liver Specimens: A Portable Ambient Light-Compatible Spectroscopic Probe.人体肝脏标本中轻度至重度全球和大泡性脂肪变性的评估:一种便携式环境光兼容光谱探针。
J Biophotonics. 2024 Dec;17(12):e202400292. doi: 10.1002/jbio.202400292. Epub 2024 Oct 13.
7
Hybrid Quantum Image Classification and Federated Learning for Hepatic Steatosis Diagnosis.用于肝脂肪变性诊断的混合量子图像分类与联邦学习
Diagnostics (Basel). 2024 Mar 6;14(5):558. doi: 10.3390/diagnostics14050558.
8
Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts.使用脂肪变性移植物进行肝移植后的结果:重新定义脂肪变性移植物的可接受阈值。
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S5-S14. doi: 10.5005/jp-journals-10018-1361.
9
Real-time assessment of liver fat content using a filter-based Raman system operating under ambient light through lock-in amplification.使用基于滤波器的拉曼系统,通过锁相放大在环境光下实时评估肝脏脂肪含量。
Biomed Opt Express. 2022 Sep 9;13(10):5231-5245. doi: 10.1364/BOE.467849. eCollection 2022 Oct 1.
10
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.晚期糖基化终产物:巴西 ELSA 研究中用于非酒精性脂肪性肝病风险分层的潜在生物标志物。
World J Gastroenterol. 2021 Aug 7;27(29):4913-4928. doi: 10.3748/wjg.v27.i29.4913.